Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
April 10, 2009
Federal Trade Commission et al v. Actavis, Inc.
Case Number:
1:09-cv-00955
Court:
Nature of Suit:
Judge:
Firms
- Alston & Bird
- Fellows LaBriola
- Giacoma Roberts
- Greenberg Traurig
- Kirkland & Ellis
- K&L Gates
- Locke Lord
- Mayer Brown
- Morris Manning
- Munger Tolles
- Skadden Arps
- Stites & Harbison
- White & Case
Companies
- AbbVie Inc.
- Allergan PLC
- Paddock Laboratories Inc.
- Par Pharmaceutical Cos. Inc.
- Teva Pharmaceutical Industries Ltd.
Government Agencies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
February 28, 2019
Original FTC V. Actavis Case Ends With AbbVie AndroGel Deal
AbbVie Inc. has agreed not to enter settlements that illegally delay the entry of certain generic drugs, allowing it to avoid a related trial over its testosterone treatment AndroGel slated to start Monday and officially putting an end to the landmark Federal Trade Commission v. Actavis litigation, the agency said Thursday.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login